Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Salciccia, Stefano, Capriotti, Anna Laura, Laganà, Aldo, Fais, Stefano, Logozzi, Mariantonia, De Berardinis, Ettore, Busetto, Gian Maria, Di Pierro, Giovanni Battista, Ricciuti, Gian Piero, Del Giudice, Francesco, Sciarra, Alessandro, Carroll, Peter R., Cooperberg, Matthew R., Sciarra, Beatrice, Maggi, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122596/
https://www.ncbi.nlm.nih.gov/pubmed/33922033
http://dx.doi.org/10.3390/ijms22094367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122596/
https://www.ncbi.nlm.nih.gov/pubmed/33922033
http://dx.doi.org/10.3390/ijms22094367

Ejemplares similares